The role of hemoglobin A1c (HbA1c) testing in the management of diabetic patients is established. More recently, the medical community has recognized its clinical utility in the disease’s diagnosis. In 2009, several major associations, including the IDF, ADA, and EASD, were part of an International Expert Committee that accepted the A1c test for diabetes diagnosis. In September 2012, the intended use for Siemens DCA® HbA1c test kit1 was expanded to include new utility as an aid to diagnose diabetes and identify patients at risk for developing the disease.
Learn more about putting this powerful tool to work in your practice by clicking the boxes below.
Not all product offerings are available in all countries. Not available for sale in the U.S./Kit #: 10698915.
Standards of Medical Care in Diabetes - DIABETES CARE, VOLUME 35, SUPPLEMENT 7, 1. January 2012.
Thaler LM, Ziemer DC, Gallina DL, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22:1415-1421.
Miller CD, Barned CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26:1158-1163.
Cagliero E, Levina DV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in Type 1 and insulin-treated Type 2 diabetic patients. Diabetes Care. 1999;22:1785-1789.
DCA Systems Hemoglobin A1c Addendum to Instructions for Use. 10698776 Rev A, 2012-08.
International Diabetes Federation. IDF Diabetes Atlas Fifth Edition. Available at: http://www.idf.org/diabetesatlas/europe. Accessed 8/2/12.